EXEL
Exelixis, Inc. - Common Stock (EXEL)
$01
About Exelixis, Inc. - Common Stock (EXEL)
Exelixis, Inc. is an oncology company, which focuses on discovering, developing, and commercialization of new medicines for difficult-to-treat cancers. Its products include cabometyx, cometriq, and cotellic. The company was founded by Stelios Papadopoulos on November 15, 1994, and is headquartered in Alameda, CA.
Details
Daily high
$59.26
Daily low
$58.46
Price at open
$58.50
52 Week High
$59.72
52 Week Low
$33.76
Market cap
14.6B
Dividend yield
-
Volume
1.6M
Avg. volume
2.2M
P/E ratio
18.53
Exelixis, Inc. - Common Stock News
Details
Daily high
$59.26
Daily low
$58.46
Price at open
$58.50
52 Week High
$59.72
52 Week Low
$33.76
Market cap
14.6B
Dividend yield
-
Volume
1.6M
Avg. volume
2.2M
P/E ratio
18.53